In gliomas, the expression of RECQ1 is highly elevated, whereas it is low in healthy brain tissue, as demonstrated by immunohistochemical analysis of tissue samples from patients, making RECQ1 a potential molecular target for the treatment of this type of tumour [8]. The gene discussed is RECQL; the disease is central nervous system cancer.